nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Breast pain—Spironolactone—dilated cardiomyopathy	0.0262	0.0262	CcSEcCtD
Gadoversetamide—Local reaction—Furosemide—dilated cardiomyopathy	0.0224	0.0224	CcSEcCtD
Gadoversetamide—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.021	0.021	CcSEcCtD
Gadoversetamide—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.0153	0.0153	CcSEcCtD
Gadoversetamide—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0136	0.0136	CcSEcCtD
Gadoversetamide—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.0126	0.0126	CcSEcCtD
Gadoversetamide—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.0115	0.0115	CcSEcCtD
Gadoversetamide—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0114	0.0114	CcSEcCtD
Gadoversetamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0108	0.0108	CcSEcCtD
Gadoversetamide—Breast pain—Lisinopril—dilated cardiomyopathy	0.0107	0.0107	CcSEcCtD
Gadoversetamide—Accidental injury—Lisinopril—dilated cardiomyopathy	0.0105	0.0105	CcSEcCtD
Gadoversetamide—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.0105	0.0105	CcSEcCtD
Gadoversetamide—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Gadoversetamide—Oliguria—Lisinopril—dilated cardiomyopathy	0.0101	0.0101	CcSEcCtD
Gadoversetamide—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00979	0.00979	CcSEcCtD
Gadoversetamide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00959	0.00959	CcSEcCtD
Gadoversetamide—Thirst—Furosemide—dilated cardiomyopathy	0.00947	0.00947	CcSEcCtD
Gadoversetamide—Neck pain—Lisinopril—dilated cardiomyopathy	0.00943	0.00943	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00926	0.00926	CcSEcCtD
Gadoversetamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00905	0.00905	CcSEcCtD
Gadoversetamide—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00905	0.00905	CcSEcCtD
Gadoversetamide—Malaise—Spironolactone—dilated cardiomyopathy	0.009	0.009	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00844	0.00844	CcSEcCtD
Gadoversetamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00839	0.00839	CcSEcCtD
Gadoversetamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.00821	0.00821	CcSEcCtD
Gadoversetamide—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00816	0.00816	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00814	0.00814	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00797	0.00797	CcSEcCtD
Gadoversetamide—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00795	0.00795	CcSEcCtD
Gadoversetamide—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00781	0.00781	CcSEcCtD
Gadoversetamide—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00742	0.00742	CcSEcCtD
Gadoversetamide—Injury—Lisinopril—dilated cardiomyopathy	0.00736	0.00736	CcSEcCtD
Gadoversetamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.00724	0.00724	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00703	0.00703	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00703	0.00703	CcSEcCtD
Gadoversetamide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00693	0.00693	CcSEcCtD
Gadoversetamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00679	0.00679	CcSEcCtD
Gadoversetamide—Diplopia—Lisinopril—dilated cardiomyopathy	0.00676	0.00676	CcSEcCtD
Gadoversetamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00671	0.00671	CcSEcCtD
Gadoversetamide—Face oedema—Lisinopril—dilated cardiomyopathy	0.00653	0.00653	CcSEcCtD
Gadoversetamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00647	0.00647	CcSEcCtD
Gadoversetamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00644	0.00644	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00633	0.00633	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00616	0.00616	CcSEcCtD
Gadoversetamide—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00611	0.00611	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00605	0.00605	CcSEcCtD
Gadoversetamide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.006	0.006	CcSEcCtD
Gadoversetamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00589	0.00589	CcSEcCtD
Gadoversetamide—Asthma—Lisinopril—dilated cardiomyopathy	0.00584	0.00584	CcSEcCtD
Gadoversetamide—Influenza—Lisinopril—dilated cardiomyopathy	0.00584	0.00584	CcSEcCtD
Gadoversetamide—Eye disorder—Furosemide—dilated cardiomyopathy	0.00583	0.00583	CcSEcCtD
Gadoversetamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.00581	0.00581	CcSEcCtD
Gadoversetamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00576	0.00576	CcSEcCtD
Gadoversetamide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00575	0.00575	CcSEcCtD
Gadoversetamide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Gadoversetamide—Angiopathy—Furosemide—dilated cardiomyopathy	0.00566	0.00566	CcSEcCtD
Gadoversetamide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00563	0.00563	CcSEcCtD
Gadoversetamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00557	0.00557	CcSEcCtD
Gadoversetamide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00557	0.00557	CcSEcCtD
Gadoversetamide—Dysuria—Lisinopril—dilated cardiomyopathy	0.00546	0.00546	CcSEcCtD
Gadoversetamide—Erythema—Furosemide—dilated cardiomyopathy	0.00543	0.00543	CcSEcCtD
Gadoversetamide—Malnutrition—Furosemide—dilated cardiomyopathy	0.00543	0.00543	CcSEcCtD
Gadoversetamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00538	0.00538	CcSEcCtD
Gadoversetamide—Flatulence—Furosemide—dilated cardiomyopathy	0.00535	0.00535	CcSEcCtD
Gadoversetamide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00531	0.00531	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00527	0.00527	CcSEcCtD
Gadoversetamide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00524	0.00524	CcSEcCtD
Gadoversetamide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00522	0.00522	CcSEcCtD
Gadoversetamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00518	0.00518	CcSEcCtD
Gadoversetamide—Rash—Spironolactone—dilated cardiomyopathy	0.00513	0.00513	CcSEcCtD
Gadoversetamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00513	0.00513	CcSEcCtD
Gadoversetamide—Vision blurred—Furosemide—dilated cardiomyopathy	0.00511	0.00511	CcSEcCtD
Gadoversetamide—Headache—Spironolactone—dilated cardiomyopathy	0.0051	0.0051	CcSEcCtD
Gadoversetamide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00506	0.00506	CcSEcCtD
Gadoversetamide—Agitation—Furosemide—dilated cardiomyopathy	0.00499	0.00499	CcSEcCtD
Gadoversetamide—Haematuria—Lisinopril—dilated cardiomyopathy	0.00497	0.00497	CcSEcCtD
Gadoversetamide—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00491	0.00491	CcSEcCtD
Gadoversetamide—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00489	0.00489	CcSEcCtD
Gadoversetamide—Vertigo—Furosemide—dilated cardiomyopathy	0.00488	0.00488	CcSEcCtD
Gadoversetamide—Nausea—Spironolactone—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Gadoversetamide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Hallucination—Lisinopril—dilated cardiomyopathy	0.00465	0.00465	CcSEcCtD
Gadoversetamide—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00464	0.00464	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00462	0.00462	CcSEcCtD
Gadoversetamide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00461	0.00461	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00459	0.00459	CcSEcCtD
Gadoversetamide—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00459	0.00459	CcSEcCtD
Gadoversetamide—Dry mouth—Furosemide—dilated cardiomyopathy	0.00452	0.00452	CcSEcCtD
Gadoversetamide—Confusional state—Furosemide—dilated cardiomyopathy	0.00447	0.00447	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00443	0.00443	CcSEcCtD
Gadoversetamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00442	0.00442	CcSEcCtD
Gadoversetamide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00436	0.00436	CcSEcCtD
Gadoversetamide—Shock—Furosemide—dilated cardiomyopathy	0.00436	0.00436	CcSEcCtD
Gadoversetamide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Gadoversetamide—Flushing—Lisinopril—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Gadoversetamide—Skin disorder—Furosemide—dilated cardiomyopathy	0.0043	0.0043	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00428	0.00428	CcSEcCtD
Gadoversetamide—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00424	0.00424	CcSEcCtD
Gadoversetamide—Anorexia—Furosemide—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Gadoversetamide—Chills—Lisinopril—dilated cardiomyopathy	0.0042	0.0042	CcSEcCtD
Gadoversetamide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00418	0.00418	CcSEcCtD
Gadoversetamide—Hypotension—Furosemide—dilated cardiomyopathy	0.00414	0.00414	CcSEcCtD
Gadoversetamide—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0041	0.0041	CcSEcCtD
Gadoversetamide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00407	0.00407	CcSEcCtD
Gadoversetamide—Erythema—Lisinopril—dilated cardiomyopathy	0.00407	0.00407	CcSEcCtD
Gadoversetamide—Flatulence—Lisinopril—dilated cardiomyopathy	0.00401	0.00401	CcSEcCtD
Gadoversetamide—Tension—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Gadoversetamide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Gadoversetamide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00398	0.00398	CcSEcCtD
Gadoversetamide—Nervousness—Lisinopril—dilated cardiomyopathy	0.00395	0.00395	CcSEcCtD
Gadoversetamide—Back pain—Lisinopril—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Gadoversetamide—Somnolence—Furosemide—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Gadoversetamide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00391	0.00391	CcSEcCtD
Gadoversetamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00385	0.00385	CcSEcCtD
Gadoversetamide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00384	0.00384	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00382	0.00382	CcSEcCtD
Gadoversetamide—Fatigue—Furosemide—dilated cardiomyopathy	0.00382	0.00382	CcSEcCtD
Gadoversetamide—Tremor—Lisinopril—dilated cardiomyopathy	0.00382	0.00382	CcSEcCtD
Gadoversetamide—Pain—Furosemide—dilated cardiomyopathy	0.00379	0.00379	CcSEcCtD
Gadoversetamide—Constipation—Furosemide—dilated cardiomyopathy	0.00379	0.00379	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00378	0.00378	CcSEcCtD
Gadoversetamide—Malaise—Lisinopril—dilated cardiomyopathy	0.00367	0.00367	CcSEcCtD
Gadoversetamide—Vertigo—Lisinopril—dilated cardiomyopathy	0.00366	0.00366	CcSEcCtD
Gadoversetamide—Syncope—Lisinopril—dilated cardiomyopathy	0.00365	0.00365	CcSEcCtD
Gadoversetamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00365	0.00365	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00362	0.00362	CcSEcCtD
Gadoversetamide—Palpitations—Lisinopril—dilated cardiomyopathy	0.0036	0.0036	CcSEcCtD
Gadoversetamide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00358	0.00358	CcSEcCtD
Gadoversetamide—Cough—Lisinopril—dilated cardiomyopathy	0.00355	0.00355	CcSEcCtD
Gadoversetamide—Urticaria—Furosemide—dilated cardiomyopathy	0.00352	0.00352	CcSEcCtD
Gadoversetamide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0035	0.0035	CcSEcCtD
Gadoversetamide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0035	0.0035	CcSEcCtD
Gadoversetamide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00347	0.00347	CcSEcCtD
Gadoversetamide—Myalgia—Lisinopril—dilated cardiomyopathy	0.00347	0.00347	CcSEcCtD
Gadoversetamide—Chest pain—Lisinopril—dilated cardiomyopathy	0.00347	0.00347	CcSEcCtD
Gadoversetamide—Anxiety—Lisinopril—dilated cardiomyopathy	0.00345	0.00345	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00344	0.00344	CcSEcCtD
Gadoversetamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.00343	0.00343	CcSEcCtD
Gadoversetamide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00339	0.00339	CcSEcCtD
Gadoversetamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.00335	0.00335	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00332	0.00332	CcSEcCtD
Gadoversetamide—Oedema—Lisinopril—dilated cardiomyopathy	0.00332	0.00332	CcSEcCtD
Gadoversetamide—Shock—Lisinopril—dilated cardiomyopathy	0.00327	0.00327	CcSEcCtD
Gadoversetamide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00325	0.00325	CcSEcCtD
Gadoversetamide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00324	0.00324	CcSEcCtD
Gadoversetamide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00323	0.00323	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00321	0.00321	CcSEcCtD
Gadoversetamide—Asthenia—Furosemide—dilated cardiomyopathy	0.00318	0.00318	CcSEcCtD
Gadoversetamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.00317	0.00317	CcSEcCtD
Gadoversetamide—Pruritus—Furosemide—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Gadoversetamide—Hypotension—Lisinopril—dilated cardiomyopathy	0.00311	0.00311	CcSEcCtD
Gadoversetamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Gadoversetamide—Insomnia—Lisinopril—dilated cardiomyopathy	0.00301	0.00301	CcSEcCtD
Gadoversetamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Gadoversetamide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Gadoversetamide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Gadoversetamide—Dizziness—Furosemide—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Gadoversetamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Gadoversetamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00289	0.00289	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Pain—Lisinopril—dilated cardiomyopathy	0.00284	0.00284	CcSEcCtD
Gadoversetamide—Constipation—Lisinopril—dilated cardiomyopathy	0.00284	0.00284	CcSEcCtD
Gadoversetamide—Vomiting—Furosemide—dilated cardiomyopathy	0.00282	0.00282	CcSEcCtD
Gadoversetamide—Rash—Furosemide—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Gadoversetamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Gadoversetamide—Headache—Furosemide—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00264	0.00264	CcSEcCtD
Gadoversetamide—Nausea—Furosemide—dilated cardiomyopathy	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Gadoversetamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00227	0.00227	CcSEcCtD
Gadoversetamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Rash—Lisinopril—dilated cardiomyopathy	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Headache—Lisinopril—dilated cardiomyopathy	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Nausea—Lisinopril—dilated cardiomyopathy	0.00197	0.00197	CcSEcCtD
